How patients participate in lung and esophageal cancer care
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This study looks at how much patients with lung or esophageal cancer get involved in decisions about their care when they receive chemotherapy and radiation together. It aims to learn what helps or challenges patients in taking an active role.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a certain type of lung or esophageal cancer that has not spread far, but is locally advanced.
- You must be scheduled to receive chemotherapy along with radiation (and possibly immunotherapy).
- You need to be between 18 and 75 years old.
- You must be able to talk with your doctor and understand what they say.
- You cannot have memory or thinking problems that make communication hard.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study monitors how the heart and lungs respond to radiation therapy combined with immunotherapy for locally advanced lung cancer. It aims to learn how well patients tolerate treatment and to detect early signs of side effects.
This trial tests whether adding immunotherapy to standard chemoradiation (chemotherapy plus radiation) can help preserve the esophagus and avoid surgery in people with resectable esophageal cancer. It aims to see if this combination is safer and more effective than current treatment.
This study follows adults with confirmed lung cancer as they are diagnosed and treated in routine clinical practice. It aims to better understand how lung cancer is diagnosed and managed day-to-day, which may help improve future care.
This study helps hospitals use the latest lung cancer guidelines better. If you have NSCLC or ES-SCLC and haven't had recent treatment, this trial may help improve the quality of care you receive.
This is an observational study of people with lung cancer. The goal is to better understand care patterns and outcomes; joining would involve giving consent and answering study questions.
This trial compares two approaches for people with esophageal cancer that has shrunk or disappeared after initial chemotherapy combined with immunotherapy. It looks at whether adding targeted radiation (DCRT) or surgery is better. The goal is to find the most effective next step for eligible patients.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.